share_log
Reuters ·  05:30
Merck & Co Inc - to Discontinue Phase 3 Keyvibe-006 Trial and Other Vibostolimab Studies
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment